| Date | Quarter | Session | EPS (est → actual) | Revenue (est → actual) |
|---|---|---|---|---|
| Nov 2, 2026Next | Q1 2027 | — | 1.14 | 1.90 B |
Sep 1, 2026
ADRNY vs. CLX: Which Stock Is the Better Value Option?
Aug 24, 2026
Omega Healthcare, Clorox and Ashland have each raised dividends and offer growth catalysts, making them worth a look for investors seeking both income and total return potential.
Clorox (CLX) technical breakout setup: 8/10 ratings, bull flag, entry near $108.26, stop $104.14. Strong trend and consolidation.
Aug 23, 2026
Clorox (CLX) has drawn fresh attention after a recent move in its share price, with the stock closing at $106.69. Investors are weighing how this level aligns with the company’s fundamentals and recent returns. See our latest analysis for Clorox. The recent move to a US$106.69 share price comes after a 30 day share price return of 11.66% and a 90 day share price return of 12.18%. However, the 1 year total shareholder return has declined 7.19% and the 5 year total shareholder return has...
Aug 22, 2026
Clorox stock has recovered some ground in the short term, yet over the past five years shareholders have seen the share price decline about 23%, while current valuation checks still lean toward the shares looking expensive rather than like a clear bargain. Over the past five years, Clorox has delivered a share price decline of about 23%, which raises questions about how much long term value recent gains are really adding for holders. Management expects supply chain efficiencies from a new...
Aug 21, 2026
CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
The Clorox Company remains a market leader but faces recent revenue and profit declines. Click here to read this latest analysis of CLX stock.
Aug 19, 2026
The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Wednesday, September 9, in Boston.
Aug 18, 2026
Church & Dwight Co., Inc. (NYSE:CHD) and The Clorox Company (NYSE:CLX) look quite different when it comes to dividends. CHD offers a much lower yield, but its dividend is growing faster. Clorox gives investors far more income today, though the company has been much more conservative with recent increases. Church & Dwight Co., Inc. (NYSE:CHD) […]
Aug 13, 2026
As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Aug 12, 2026
Clorox’s second quarter generated a positive response from investors, as revenue surpassed analyst expectations despite a 2% year-over-year decline. Management attributed the quarter’s performance to targeted improvements in product superiority, focused brand investments, and effective promotional execution in key categories. CEO Linda Rendle noted that, “the majority of our businesses are performing at or above expectations,” while acknowledging operational challenges in segments like Litter an
